Camber Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-291,600
| Closed | -$14.7M | – | 31 |
|
|
2019
Q1 | $14.7M | Hold |
291,600
| – | – | 0.73% | 24 |
|
|
2018
Q4 | $11.7M | Hold |
291,600
| – | – | 0.56% | 28 |
|
|
2018
Q3 | $20.2M | Buy |
291,600
+30,500
| +12% | +$2.11M | 0.87% | 22 |
|
|
2018
Q2 | $19.8M | Buy |
+261,100
| New | +$19.8M | 0.76% | 28 |
|
|
2015
Q1 | – | Sell |
-200,400
| Closed | -$3.11M | – | 44 |
|
|
2014
Q4 | $3.11M | Buy |
+200,400
| New | +$3.11M | 0.21% | 36 |
|